Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors

European Journal of Cancer

Volumn 51, Issue 2, 2015, Pages 210-217

  Palmerini, Emanuela ^a   Staals, Eric L ^a   Maki, Robert G ^e   Pengo, Stefano ^c   Cioffi, Angela ^b   Gambarotti, Marco ^a   Picci, Piero ^a   Daolio, Primo Andrea ^d   Parafioriti, Antonina ^d   Morris, Carol ^b   Antonescu, Cristina R ^b   Gronchi, Alessandro ^c   Casali, Paolo Giovanni ^c   Donati, Davide M ^a   Ferrari, Stefano ^a   Stacchiotti, Silvia ^c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Pigmented villonodular synovitis; Prognostic factors; Tenosynovial giant cell tumour; Treatment; Tyrosine kinase inhibitors

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IMATINIB;

ADULT; AGED; ARTHROSCOPY; ARTICLE; BENIGN TUMOR; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LOCAL FAILURE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYNOVIUM; TENDON SHEATH; TENOSYNOVIAL GIANT CELL TUMOUR; TUMOR RECURRENCE; TUMOR VOLUME; ADOLESCENT; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GIANT CELL TUMORS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SYNOVITIS, PIGMENTED VILLONODULAR; TENDON; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GIANT CELL TUMORS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RETROSPECTIVE STUDIES; SYNOVIAL MEMBRANE; SYNOVITIS, PIGMENTED VILLONODULAR; TENDONS; TIME FACTORS; YOUNG ADULT;

EID: 84925446588     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.11.001     Document Type: Article

References (36)

1. Somerhausen N, de S, van de Rijn M. Tenosynovial giant cell tumour, diffuse type. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO classification of tumours of soft tissue and bone. 4th edition. Lyon: IARC; 2013. p. 102-3.
2. H. Mankin, C. Trahan, and F. Hornicek Pigmented villonodular synovitis of joints J Surg Oncol 103 2011 386 389
3. R.B. West, B.P. Rubin, and M.A. Miller A landscape effect in tenosynovial-giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells Proc Natl Acad Sci USA 103 2006 690 695
4. J.X. O'Connell Pathology of the synovium Am J Clin Pathol 114 2000 773 784
5. Greenspan A, Remagen W. Tumors and tumor-like lesions of the joints. In: Greenspan A, Remagen W., editors. Differential diagnosis of tumors and tumor-like lesions of bones and joints. Philadelphia: Lippincott Raven; 1998. p. 389-422.
6. R. Sciot, J. Rosai, and P. Dal Cin Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the chromosomes and morphology (CHAMP) study group Genes Chromosomes Cancer 6 1993 212 217
7. S. Ottaviani, X. Ayral, and M. Dougados Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature Semin Arthritis Rheum 40 2011 539 546
8. H.S. Schwartz, K.K. Unni, and D.J. Pritchard Pigmented villonodular synovitis: a retrospective review of affected large joints Clin Orthop Relat Res 247 1989 243 255
9. R. Heyd, O. Micke, and B. Berger Radiation therapy for treatment of pigmented villonodular synovitis: results of a national patterns of care study Int J Radiat Oncol Biol Phys 78 2010 199 204
10. D.G. Mohler, and B.D. Kessler Open synovectomy with cryosurgical adjuvant for treatment of diffuse pigmented villonodular synovitis of the knee Bull Hosp Jt Dis 59 2 2000 99 105
11. P.A. Cassier, H. Gelderblom, and S. Stacchiotti Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis Cancer 118 2012 1649 1655
12. Gelderblom H, Pérol D, Chevreau C, et al. An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment. J Clin Oncol 2013;31 [suppl; abstr 10516].
13. Tap WD, Anthony SP, Chmielowski B, et al. A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS). J Clin Oncol 2014; 32:5s. [suppl; abstr 10503].
14. Cassier PA, Gomez-Roca CA, Italiano A, et al. Phase 1 study of RG7155, a novel anti-CSF1R antibody, in patients with locally advanced pigmented villonodular synovitis (PVNS). J Clin Oncol 2014;32:5s [suppl; abstr 10504].
15. < http://clinicaltrials.gov/show/NCT01643850 >.
16. W.F. Enneking, W. Dunham, and M.C. Gebhardt A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system Clin Orthop Relat Res 286 1993 241 246
17. W.E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
18. D.J. Ogilvie-Harris, J. McLean, and M.E. Zarnett Pigmented villonodular synovitis of the knee. The results of total arthroscopic synovectomy, partial, arthroscopic synovectomy, and arthroscopic local excision J Bone Joint Surg Am 74 1992 119 123
19. E. De Visser, R.P. Veth, and M. Pruszczynski Diffuse and localized pigmented villonodular synovitis: evaluation of treatment of 38 patients Arch Orthop Trauma Surg 119 1999 401 404
20. V. Ravi, W.L. Wang, and V.O. Lewis Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis Curr Opin Oncol 23 2011 361 366
21. B.R. Hamlin, G.P. Duffy, and R.T. Trousdale Total knee arthroplasty in patients who have pigmented villonodular synovitis J Bone Joint Surg Am 80 1998 76 82
22. J.E. Johansson, S. Ajjoub, and L.P. Coughlin Pigmented villonodular synovitis of joints Clin Orthop Relat Res 163 1982 159 166
23. J.S. Dines, T.M. DeBerardino, and J.L. Wells Long-term follow-up of surgically treated localized pigmented villonodular synovitis of the knee Arthroscopy 23 2007 930 937
24. C. Chiari, C. Pirich, and W. Brannath What affects the recurrence and clinical outcome of pigmented villonodular synovitis? Clin Orthop Relat Res 450 2006 172 178
25. V. Sharma, and E.Y. Cheng Outcomes after excision of pigmented villonodular synovitis of the knee Clin Orthop Relat Res 467 2009 2852 2858
26. K.R. Chin, S.J. Barr, and C. Winalski Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee J Bone Joint Surg Am 84 2002 2192 2202
27. C.E. Blanco, H.O. Leon, and T.B. Guthrie Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee Arthroscopy 17 2001 527 531
28. Pinaroli A, Aït Si Selmi T, Servien E, et al. Surgical management of pigmented villonodular synovitis of the knee: retrospective analysis of 28 cases. Rev Chir Orthop Reparatrice Appar Mot 2006;92:437-47.
29. V.F. Ustinova, E.L. Podliashuk, and S.S. Rodionova Combined treatment of the diffuse form of pigmented villonodular synovitis Med Radiol (Mosk) 31 1986 27 31
30. H.J. Yoon, Y.A. Cho, and J.I. Lee Malignant pigmented villonodular synovitis of the temporomandibular joint with lung metastasis: a case report and review of the literature Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 2011 30 36
31. P.P. Kotwal, V. Gupta, and R. Malhotra Giant-cell tumour of the tendon sheath. Is radiotherapy indicated to prevent recurrence after surgery? J Bone Joint Surg Br 82 2000 571 573
32. B. O'Sullivan, B. Cummings, and C. Catton Outcome following radiation treatment for high-risk pigmented villonodular synovitis Int J Radiat Oncol Biol Phys 32 1995 777 786
33. K.K. Tanabe, R.E. Pollock, and L.M. Ellis Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas Cancer 73 1994 1652 1659
34. A. Gronchi, P. Verderio, and A. De Paoli Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall Ann Oncol 24 2013 817 823
35. A.L. Dewar, A.C. Cambareri, and A.C. Zannettino Macrophage colony-stimulating factor receptor c-FMS is a novel target of imatinib Blood 105 2005 3127 3132
36. J.S. Cupp, M.A. Miller, and K.D. Montgomery Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides Am J Surg Pathol 31 2007 970 976